A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS

Not Applicable

Completed

• Conditions: Cryptosporidiosis; HIV Infections

• Registration Number: NCT00002278
• Lead Sponsor: Janssen, LP

Brief Summary

To evaluate the safety and efficacy of diclazuril capsules as a treatment for cryptosporidial related diarrhea in AIDS patients who have been treated in the double-blind study # JRD 64,433/1101 and have relapsed, or de-novo patients who have been diagnosed with cryptosporidial related diarrhea and who meet the inclusion and exclusion criteria of this protocol.

Detailed Description

Not available

Study Timeline

• Status Verified: 1990-07
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (3)

Saint Luke's - Roosevelt Hosp Ctr; 🇺🇸 New York, New York, United States

Bellevue Hosp / New York Univ Med Ctr; 🇺🇸 New York, New York, United States

Cornell Univ Med Ctr; 🇺🇸 New York, New York, United States